FDA Increases PDUFA Program Fee For Fiscal 2021, Cites COVID Workload

By Beth Wang / July 29, 2020 at 7:48 PM
FDA announced Wednesday (July 29) that it will decrease application costs for its prescription drug user fee program in fiscal 2021, but it will increase overall program fees by about $11,000 over fiscal 2020 levels, for a total of about $336,000. The agency also is increasing medical device user fees across the board in fiscal 2021. FDA, in a Federal Register notice announcing the Prescription Drug User Fee Amendment fees for fiscal 2021, says it believes it will need...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.